BMI1 and cancer: Surprisingly, CBP treatment had no effect on BMI-1 expression in ovarian spheroids, whereas DHA treatment markedly reduced the expression of BMI-1 and several other CSC markers, which reduced the number of spheroids, attenuated CSC self-renewal activity and cancer growth and improved CBP sensitivity.